The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 1.09 — distress zone — historically elevated failure riskWatch
- Earnings quality 94/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as AVANOS MEDICAL, INC. reports it. History and quarterly detail are in the app.
- Total Specialty Nutrition Systems$432.9M
- Total Pain Management and Recovery$237.8M
- Corporate and other$30.5M
Leadership changes
From AVANOS MEDICAL, INC.'s own filings, the day they're filed.
- Kerr Holbrook · Chief Commercial Officer · departureeff. 2025-12-01
- Mojirade James · President · departureeff. 2025-12-01
- Michael C. Greiner · departureeff. 2025-04-28
Latest filings
- 8-K · Company announcement2026-05-05
- 10-Q · Quarterly report2026-05-05
- 8-K · Company announcement2026-04-14
- DEF 14A · Annual proxy (pay & governance)2026-03-12
- 8-K · Company announcement2026-03-12
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about AVANOS MEDICAL, INC., every answer cited🔒
- The Intelligence Brief — added when AVANOS MEDICAL, INC.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.